←
Nirvan Mullick10,732 posts
Nirvan Mullick avatar

Nirvan Mullick

@nirvan

Film + Maker / @cainesarcade @whatatripfilm @lawnchairpilot / impact @imagination

◷ Joined April 2008▧ 781 Photos and videos
Isaiah Saxon avatar
⟳ Nirvan Mullick retweeted
Isaiah Saxon@isaiah_saxon_·27 Apr 2025

sunday afternoon ✨THE LEGEND OF OCHI✨ is playing near you. bring your friends, they'll love it. bring your kids, they'll go wild. bring your dog, they'll look at you with renewed fondness, the depth of your bond suddenly vivid, with a clarity that was previously unarticulated.

1:02
The Legend of Ochi avatar
⟳ Nirvan Mullick retweeted
The Legend of Ochi@ochimovie·28 Apr 2025

“The spirits of Henson and Spielberg are thriving.” (@thedailybeast) Experience THE LEGEND OF OCHI – now playing nationwide

0:29
The Legend of Ochi avatar
⟳ Nirvan Mullick retweeted
The Legend of Ochi@ochimovie·27 Apr 2025

A snack for the road. THE LEGEND OF OCHI is now playing nationwide.

0:31
Nirvan Mullick avatar
Nirvan Mullick@nirvan·2 Feb 2025

Excited to see this. @isaiah_saxon_ has been working to bring this magical creature into the world for over a decade.

I completely adored THE LEGEND OF OCHI. It pulls inspiration from Amblin movies like E.T., Jim Henson's classics, and even Ghibli, but still takes tons of *weird* swings that create its own identity full of wonder. They literally don't make family adventures like this anymore.

Post attachment
Variety avatar
⟳ Nirvan Mullick retweeted
Variety@Variety·27 Jan 2025

‘The Legend of Ochi’ Review: Practical Magic Breathes Life Into A24’s Grounded Fantasy Preaching Man's Coexistence With Nature variety.com/2025/film/review…

Isaiah Saxon avatar
⟳ Nirvan Mullick retweeted
Isaiah Saxon@isaiah_saxon_·16 Oct 2024

hi friends we made a movie. 🎷🐛

A24@A2416 Oct 2024

Something else is out there 🏔️ Discover THE LEGEND OF OCHI, a bold new wonder from filmmaker Isaiah Saxon. Starring Helena Zengel, Finn Wolfhard, Emily Watson, and Willem Dafoe. Coming soon.

2:24
Nancy Buck avatar
⟳ Nirvan Mullick retweeted
Nancy Buck@JellickBuck·8 Oct 2024

24/25 Day#37b 📦Global Cardboard Challenge📦 It’s so hard to pick just a few examples of creativity when ALL of our @JelliclJaguar Designers did such an AMAZING job with their projects! 🌟 Thank you Mr @CainesArcade and Mr @nirvan for the many years of ❤️ ! 📦😃😊📦

Post attachment
1:00
Ryan Grim avatar
⟳ Nirvan Mullick retweeted
Ryan Grim@ryangrim·9 Aug 2024

The FDA’s MDMA decision is a total travesty. The study showed extraordinary efficacy but the review panel was just culturally biased against psychedelics. One panelists even said out loud she would oppose it because it would be too costly for providers and there are already treatments for PTSD

This video debunks serious flaws and mis-information in the @FDA Advisory Committee hearing (that recommended against approving MDMA Therapy to treat PTSD) and exposes how a small group of radical anti-capitalist activists called Psymposia hijacked a federal regulatory process. With the FDA poised to determine whether to approve MDMA therapy or not, this coordinated mis-information campaign by a small group of activists and ICER may derail a life saving treatment for millions. Here is how it happened: 1. Psymposia made unverified and sensationalized accusations to portray @Lykos_PBC trial data as systemically flawed. 2. Their unverified claims were then repeated by @ICER_review in a questionable report that was not fact checked, and published before the June 4th AdComm meeting. ICER is a group that helps set drug prices for the insurance and health care industry. Psymposia's unverified accusations of researcher bias, study flaws, and systemic omissions published in the ICER report were then amplified by major media outlets like @NPR and the @NYtimes. This misinformation then derailed the FDA Advisory Committee. Because of the way the hearing was structured, the trial sponsor, Lykos, was not given time to correct the myriad of misinformation discussed by the panel for several hours before the panel voted. The panel voted almost unanimously against recommending approval. The resulting press has created an inaccurate cloud of confusion casting doubt on the science and efficacy of the treatment. Fortunately, the committee's vote is non-binding. Lets urge the FDA to follow the science. #approveMDMAtherapy #MDMA4PTSD film by @nirvan featuring @laurentaus editing @umuima produced by @interconnectd @dreammullick

15:08
WHAT A TRIP avatar
⟳ Nirvan Mullick retweeted
WHAT A TRIP@WhataTripFilm·9 Aug 2024

This video debunks serious flaws and mis-information in the @FDA Advisory Committee hearing (that recommended against approving MDMA Therapy to treat PTSD) and exposes how a small group of radical anti-capitalist activists called Psymposia hijacked a federal regulatory process. With the FDA poised to determine whether to approve MDMA therapy or not, this coordinated mis-information campaign by a small group of activists and ICER may derail a life saving treatment for millions. Here is how it happened: 1. Psymposia made unverified and sensationalized accusations to portray @Lykos_PBC trial data as systemically flawed. 2. Their unverified claims were then repeated by @ICER_review in a questionable report that was not fact checked, and published before the June 4th AdComm meeting. ICER is a group that helps set drug prices for the insurance and health care industry. Psymposia's unverified accusations of researcher bias, study flaws, and systemic omissions published in the ICER report were then amplified by major media outlets like @NPR and the @NYtimes. This misinformation then derailed the FDA Advisory Committee. Because of the way the hearing was structured, the trial sponsor, Lykos, was not given time to correct the myriad of misinformation discussed by the panel for several hours before the panel voted. The panel voted almost unanimously against recommending approval. The resulting press has created an inaccurate cloud of confusion casting doubt on the science and efficacy of the treatment. Fortunately, the committee's vote is non-binding. Lets urge the FDA to follow the science. #approveMDMAtherapy #MDMA4PTSD film by @nirvan featuring @laurentaus editing @umuima produced by @interconnectd @dreammullick

15:08
Nirvan Mullick avatar
Nirvan Mullick@nirvan·11 Aug 2024

Why did Psymposia, a fringe group of anti-capitalists, hijack @Lykos_PBC @FDA app for MDMA to treat PTSD? They're opposed to all for-profits commercializing "sacred medicines" & willing to distort, sensationalize & deprive 13 million suffering/dying from PTSD to cost Lykos $$.

Why were the activists so opposed to this?

Nirvan Mullick avatar
Nirvan Mullick@nirvan·9 Aug 2024

A short film we just finished exposing how a small group of radical activists hijacked a federal regulatory process to review MDMA Therapy to treat PTSD, potentially depriving millions of people suffering from PTSD from a life saving therapy. Thnx @misstaus @umuima @dreammullick

This video debunks serious flaws and mis-information in the @FDA Advisory Committee hearing (that recommended against approving MDMA Therapy to treat PTSD) and exposes how a small group of radical anti-capitalist activists called Psymposia hijacked a federal regulatory process. With the FDA poised to determine whether to approve MDMA therapy or not, this coordinated mis-information campaign by a small group of activists and ICER may derail a life saving treatment for millions. Here is how it happened: 1. Psymposia made unverified and sensationalized accusations to portray @Lykos_PBC trial data as systemically flawed. 2. Their unverified claims were then repeated by @ICER_review in a questionable report that was not fact checked, and published before the June 4th AdComm meeting. ICER is a group that helps set drug prices for the insurance and health care industry. Psymposia's unverified accusations of researcher bias, study flaws, and systemic omissions published in the ICER report were then amplified by major media outlets like @NPR and the @NYtimes. This misinformation then derailed the FDA Advisory Committee. Because of the way the hearing was structured, the trial sponsor, Lykos, was not given time to correct the myriad of misinformation discussed by the panel for several hours before the panel voted. The panel voted almost unanimously against recommending approval. The resulting press has created an inaccurate cloud of confusion casting doubt on the science and efficacy of the treatment. Fortunately, the committee's vote is non-binding. Lets urge the FDA to follow the science. #approveMDMAtherapy #MDMA4PTSD film by @nirvan featuring @laurentaus editing @umuima produced by @interconnectd @dreammullick

15:08